DBV Technologies | DBVT - DŁUG

Cena Akcji
19.76
Dzienna Zmiana
-0.60 -2.95%
Miesięcznie
-3.87%
Rocznie
318.10%
Q1 Prognozy TE
19.99




DŁUG Zmiana Data
Acadia Pharmaceuticals USD 54.81M 1.48M 2025-09
Alnylam Pharmaceuticals USD 1.31B 11.39M 2025-09
Amarin USD 0 0 2025-03
BioCryst Pharmaceuticals USD 828.6M 510K 2024-12
BioMarin Pharmaceutical USD 604.24M 375K 2025-09
DBV Technologies USD 8.59M 295K 2025-09
Esperion Therapeutics USD 262.92M 1.76M 2024-09
Galectin Therapeutics USD 71.74M 10.6M 2023-12
Halozyme Therapeutics USD 1.51B 1.66M 2025-09
Incyte USD 40.41M 855K 2025-12
Insmed USD 727.89M 163.33M 2025-12
Ionis Pharmaceuticals USD 2.33B 1.1B 2025-12
Neurocrine Biosciences USD 428.4M 10.7M 2025-09
PTC Therapeutics USD 286.32M 306K 2025-09
Sarepta Therapeutics USD 1.25B 103.69M 2025-09
Ultragenyx Pharmaceutical USD 33.83M 2.46M 2025-09
United Therapeutics USD 200M 100M 2025-03